Loading...
Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis
C3 glomerulopathy (C3G) is characterized by C3 deposits with minimal immunoglobulin deposition caused by alternative complement pathway dysregulation. Unfortunately, no therapeutic intervention has consistently improved outcomes for patients with C3G. Eculizumab, a monoclonal antibody to C5, is curr...
Saved in:
| Published in: | Clin Kidney J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515899/ https://ncbi.nlm.nih.gov/pubmed/26251714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv044 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|